PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Chenega Corporation, contractor on assignment to the National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'PharMerica, a BrightSpring Health Services company, Louisville, Kentucky, USA.\', \'Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'CDC COVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab225
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33693607
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Trends in Prescribing of Antibiotics and Drugs Investigated for Coronavirus Disease 2019 (COVID-19) Treatment in US Nursing Home Residents During the COVID-19 Pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all